CN1127639A - 一种止血药的制备方法及其制剂 - Google Patents
一种止血药的制备方法及其制剂 Download PDFInfo
- Publication number
- CN1127639A CN1127639A CN 95100072 CN95100072A CN1127639A CN 1127639 A CN1127639 A CN 1127639A CN 95100072 CN95100072 CN 95100072 CN 95100072 A CN95100072 A CN 95100072A CN 1127639 A CN1127639 A CN 1127639A
- Authority
- CN
- China
- Prior art keywords
- hemorrhage
- examples
- fine powder
- powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 7
- 230000002439 hemostatic effect Effects 0.000 title 1
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 29
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- 241000132536 Cirsium Species 0.000 abstract 3
- 238000001914 filtration Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 14
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 208000034158 bleeding Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 208000032467 Aplastic anaemia Diseases 0.000 description 3
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010007191 Capillary fragility Diseases 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 208000024283 Gingival haemorrhages Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 208000002291 Histiocytic Sarcoma Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 1
- 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 201000008825 fibrosarcoma of bone Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000006812 malignant histiocytosis Diseases 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 206010028537 myelofibrosis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95100072A CN1059566C (zh) | 1995-01-28 | 1995-01-28 | 一种止血药的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95100072A CN1059566C (zh) | 1995-01-28 | 1995-01-28 | 一种止血药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1127639A true CN1127639A (zh) | 1996-07-31 |
CN1059566C CN1059566C (zh) | 2000-12-20 |
Family
ID=5073235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95100072A Expired - Lifetime CN1059566C (zh) | 1995-01-28 | 1995-01-28 | 一种止血药的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1059566C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1061251C (zh) * | 1997-11-14 | 2001-01-31 | 陈国秀 | 一种治疗眼内出血的中成药 |
CN1318046C (zh) * | 2003-08-22 | 2007-05-30 | 郭俊京 | 一种从小蓟植物中提取止血药物的方法 |
-
1995
- 1995-01-28 CN CN95100072A patent/CN1059566C/zh not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1061251C (zh) * | 1997-11-14 | 2001-01-31 | 陈国秀 | 一种治疗眼内出血的中成药 |
CN1318046C (zh) * | 2003-08-22 | 2007-05-30 | 郭俊京 | 一种从小蓟植物中提取止血药物的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1059566C (zh) | 2000-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066434A (zh) | 含有奥美拉唑的药物 | |
CN101066435A (zh) | 含有艾普拉唑的药物 | |
CN105362340A (zh) | 一种治疗白血病的药物组合物及其制备方法 | |
CN1059566C (zh) | 一种止血药的制备方法 | |
CN1029081C (zh) | 一种防治高脂血症病的中药的生产方法 | |
CN1951453A (zh) | 一种治疗痔疮的中药颗粒及其制备方法 | |
CN101461832A (zh) | 治疗口腔溃疡的生物粘附贴片 | |
CN100349581C (zh) | 一种治疗癌症、肿瘤及各种炎症的中药 | |
CN100548326C (zh) | 一种保护胃粘膜的中药组合物及其制备方法 | |
CN1167453C (zh) | 一种治疗痔疮的散剂 | |
CN1278727C (zh) | 一种结肠炎灌肠剂 | |
CN101066436A (zh) | 治疗胃溃疡的药物组合物 | |
CN101066416A (zh) | 含有雷贝拉唑治疗胃溃疡的药物 | |
CN117547515B (zh) | 一种含有平贝母的口腔片剂及其制备方法 | |
CN114848778B (zh) | 一种消炎止痛促进创伤愈合的复方箍围膏及其制备方法和应用 | |
CN109125703A (zh) | 一种用于治疗阴道炎的药物组合及其制备方法 | |
CN1279951C (zh) | 治疗甲亢及单纯性甲状腺肿大纯中药胶囊 | |
CN1194733C (zh) | 一种治疗甲亢的药物及制备方法 | |
CN1099625A (zh) | 保元肠疡灵 | |
CN1733098A (zh) | 一清口服液及其制备方法 | |
CN1125602A (zh) | 宫血停冲剂 | |
CN1348787A (zh) | 治疗红斑狼疮的中药制剂 | |
CN1059111C (zh) | 一种治疗肿瘤的胶囊 | |
CN1449782A (zh) | 复方仙人掌抗病毒制剂 | |
CN1183297A (zh) | 蝎毒肿瘤丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Applicant after: Qishan pharmaceutical factory of Shaanxi Applicant before: Qiao Donghu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: QIAO DONGHU TO: SHANXI QISHAN PHARMACEUTICAL FACTORY |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
COR | Change of bibliographic data |
Free format text: CORRECT: PATENTEE; FROM: SHANXI JINFANG MEDICINE CO., LTD. TO: XI AN GAOKE SHANXI JINFANG PHARMACEUTICAL INDUSTRY CO. |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: Xi'an Gaoke Shanxi Jinfang Pharmaceutical Industry Co. Patentee before: Jinfang Pharmaceutical Co., Ltd., Shaanxi |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20150128 Granted publication date: 20001220 |